Watch now: Pharma Trends 2022 Webinar
We are approaching the end of a year which saw global vaccine rollout for COVID-19, 44 novel drug approvals (to date) and the return of the CPHI Worldwide in-person event.
In this recent CPHI Webinar sponsored by Recipharm which you can watch now for free, industry experts gave their views on what 2022 has in store for the pharma industry.
Providing an overview of drug delivery trends, Andrew Donnelly, Vice President of Innovation, Bespak by Recipharm said that while the continued drive for self-administration to reduce the burden on healthcare systems and improve convenience for patients was “hardly ground-breaking news”, the events of the last two years “have really accelerated some of these requirements.”
“The global pandemic has clearly changed our attitudes to remote working, remote relationships and our acceptance of remote healthcare, removing some of the resistance and fear of the absence of face to face consultations that previously existed,” he added.
Gian Paolo Negrisoli, CEO, Flamma Spa told the webinar that there was “no shortage” in terms of the number of small molecule new molecular entities reaching the market or entering development, but made the point that requirements are changing.
He said unconventional pharma was continuing to drive innovation amid growing molecular complexity while demand was shifting to smaller volumes often with higher containment requirements and accelerated developments were becoming the rule.
“In parallel to this, sustainability and decarbonisation are increasingly coming to the top of agendas and dependence on China and India for raw materials represents a growing concern,” he added.
Focusing on biotech, Daniel Chancellor, Director, Thought Leadership, Informa Pharma Intelligence said there had been a “Cambrian explosion” of R&D innovation within the sector led by an abundant and well-funded biotech ecosystem.
He said that while some biotechs may eventually get acquired by Big Pharma – as demonstrated by recent moves for antibody and cell and gene companies – inevitably new biotechs were emerging to further progress the science and platforms.
“On the private start-up side of biotech, the fundraising environment is abundant; more venture capital was raised in the first half of this year than in any entire year prior, including 2020, which itself was a record year,” he said.
Related News
-
News Pharmapack Awards 2024 Patient-Centric Design Award Winner – Dr Ferrer BioPharma
The 2024 Pharmapack Awards celebrated the best in innovation and design for the pharmaceutical packaging and drug delivery industry on January 24, 2024. -
News Women in Pharma: Minding the Gap at Pharmapack 2024
2024 marks the first year Pharmapack will host a Diversity track dedicated to bridging the gap within the pharmaceutical packaging and drug delivery sector. The track includes a panel discussion on 'Enabling Diversity in the Workplace,' focused... -
News Pharmapack Awards 2024 - Celebrating Packaging and Drug Delivery Innovation
The 2024 Pharmapack Innovation Awards ceremony celebrated the best in pharmaceutical packaging and drug delivery innovation at all levels. The awards were held on January 24, 2024 at the Paris Expo Porte de Versailles. -
News 2024 Pharma Industry Trends Outlook: Collaboration, Market Maturity, and Digital Futures
The annual CPHI Online 2024 Pharma Trends Outlook, in partnership with Arvato Systems, identifies 12 key industry trends shaping the life sciences industry in the coming year. -
News New Novo Nordisk AI hub for drug discovery to open in London, UK
Danish pharmaceutical giant Novo Nordisk will be opening an AI-based research facility in the heart of London to advance drug discovery operations. -
News BioNTech to begin mRNA vaccine manufacturing in Rwanda by 2025
German biotechnology company BioNTech has stated their intentions to begin production at their mRNA vaccine factory in Rwanda by 2025, which will mark the first foreign mRNA vaccine manufacturing site on the continent of Africa. -
News Women in Pharma: Looking back on 2023 and moving forward to 2024
In this monthly series, we interview women from across the pharmaceutical industry and supply chain to discuss the importance of gender diversity in healthcare, the workplace, and beyond. -
News CPHI Barcelona 2023: Partnering for Success – Managing Outsourcing Relationships to Optimise Manufacturing Operations
During CPHI Barcelona 2023, insightful content sessions offered attendees the chance to explore trending topics with expert speakers and panellists. Here, we summarise what the pharma industry and supply chain are talking about the most.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance